Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | Vandetanib | CCLE | pan-cancer | AAC | 0.26 | 3e-07 |
mRNA | Bosutinib | GDSC1000 | pan-cancer | AAC | 0.17 | 8e-06 |
mRNA | Erlotinib | CCLE | pan-cancer | AAC | 0.2 | 5e-05 |
mRNA | L-685458 | CCLE | pan-cancer | AAC | 0.2 | 6e-05 |
mRNA | EKB-569 | GDSC1000 | pan-cancer | AAC | 0.15 | 0.0001 |
mRNA | Docetaxel | GDSC1000 | pan-cancer | AAC | 0.14 | 0.0002 |
mRNA | YM201636 | GDSC1000 | pan-cancer | AAC | -0.13 | 0.0003 |
mRNA | Epothilone B | GDSC1000 | pan-cancer | AAC | 0.14 | 0.0006 |
mRNA | CH5424802 | GDSC1000 | pan-cancer | AAC | 0.13 | 0.0006 |
mRNA | PHA-665752 | CCLE | pan-cancer | AAC | 0.18 | 0.0007 |